BioDelivery Sciences Intl, Inc. Wrrt
BioDelivery Sciences Intl, Inc. Wrrt Fundamental Analysis
BioDelivery Sciences Intl, Inc. Wrrt (BDSIW) shows strong financial fundamentals with a PE ratio of 6.80, profit margin of 50.90%, and ROE of 57.33%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 78.1/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze BDSIW's fundamental strength across five key dimensions:
Efficiency Score
ExcellentBDSIW demonstrates superior asset utilization.
Valuation Score
ExcellentBDSIW trades at attractive valuation levels.
Growth Score
WeakBDSIW faces weak or negative growth trends.
Financial Health Score
ExcellentBDSIW maintains a strong and stable balance sheet.
Profitability Score
ModerateBDSIW maintains healthy but balanced margins.
Key Financial Metrics
Is BDSIW Expensive or Cheap?
P/E Ratio
BDSIW trades at 6.80 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, BDSIW's PEG of 0.07 indicates potential undervaluation.
Price to Book
The market values BioDelivery Sciences Intl, Inc. Wrrt at 3.07 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 14.20 times EBITDA. This signals the market has high growth expectations.
How Well Does BDSIW Make Money?
Net Profit Margin
For every $100 in sales, BioDelivery Sciences Intl, Inc. Wrrt keeps $50.90 as profit after all expenses.
Operating Margin
Core operations generate 22.27 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $57.33 in profit for every $100 of shareholder equity.
ROA
BioDelivery Sciences Intl, Inc. Wrrt generates $26.14 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $0.39 in free cash annually.
FCF Yield
BDSIW converts 7.04% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
6.80
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.07
vs 25 benchmark
P/B Ratio
Price to book value ratio
3.07
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.46
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.31
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.45
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.57
vs 25 benchmark
ROA
Return on assets percentage
0.26
vs 25 benchmark
ROCE
Return on capital employed
0.15
vs 25 benchmark
How BDSIW Stacks Against Its Sector Peers
| Metric | BDSIW Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 6.80 | 29.43 | Better (Cheaper) |
| ROE | 57.33% | 800.00% | Weak |
| Net Margin | 50.90% | -20145.00% (disorted) | Strong |
| Debt/Equity | 0.31 | 0.30 | Neutral |
| Current Ratio | 2.45 | 4.64 | Strong Liquidity |
| ROA | 26.14% | -17936.00% (disorted) | Strong |
BDSIW outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews BioDelivery Sciences Intl, Inc. Wrrt's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation